Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolates

Holmes, N.E., Turnidge, J.D., Munckhof, W.J., Robinson, J.O., Korman, T.M., O'Sullivan, M.V.N., Anderson, T.L., Roberts, S.A., Warren, S.J.C., Coombs, G.W.ORCID: 0000-0003-1635-6506, Tan, H-L, Gao, W., Johnson, P.D.R., Howden, B.P. and Carroll, K.C. (2014) Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolates. Journal of Clinical Microbiology, 52 (9). pp. 3384-3393.

PDF - Published Version
Download (1MB)
Link to Published Version:
*Subscription may be required


An elevated vancomycin MIC is associated with poor outcomes in Staphylococcus aureus bacteremia (SAB) and is reported in patients with methicillin-susceptible S. aureus (MSSA) bacteremia in the absence of vancomycin treatment. Here, using DNA microarray and phenotype analysis, we investigated the genetic predictors and accessory gene regulator (agr) function and their relationship with elevated vancomycin MIC using blood culture isolates from a multicenter binational cohort of patients with SAB. Specific clonal complexes were associated with elevated (clonal complex 8 [CC8] [P < 0.001]) or low (CC22 [P < 0.001], CC88 [P < 0.001], and CC188 [P = 0.002]) vancomycin MIC. agr dysfunction (P = 0.014) or agr genotype II (P = 0.043) were also associated with an elevated vancomycin MIC. Specific resistance and virulence genes were also linked to an elevated vancomycin MIC, including blaZ (P = 0.002), sea (P < 0.001), clfA (P < 0.001), splA (P = 0.001), and the arginine catabolic mobile element (ACME) locus (P = 0.02). These data suggest that inherent organism characteristics may explain the link between elevated vancomycin MICs and poor outcomes in patients with SAB, regardless of the antibiotic treatment received. A consideration of clonal specificity should be included in future research when attempting to ascertain treatment effects or clinical outcomes.

Item Type: Journal Article
Publisher: American Society for Microbiology
Copyright: © 2014, American Society for Microbiology.
Item Control Page Item Control Page


Downloads per month over past year